Mammotome is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures.
As the global market leader in vacuum-assisted breast biopsy, Mammotome has offered physicians and women a wide range of options and diagnostic tools since 1995.
The Mammotome Biopsy System is a complete system for breast tissue sampling and management. Compatible with multiple imaging modalities, the Mammotome Biopsy System enables breast biopsy to be performed under stereotactic x-ray, ultrasound, MRI or molecular imaging guidance. Mammotome offers a full array of tissue markers to mark the biopsy site for follow-up observations.
With the Mammotome Biopsy System, clinicians can achieve diagnostic confidence using a less invasive approach that offers women faster recovery, less scarring and lower costs of care as compared to open procedures.
More than 3 million women worldwide have had an image-guided, minimally invasive breast biopsy using the Mammotome Biopsy System.
